Which Genetic Tests Are Ready for Prime Time? (And Some Musings on COVID-19) With Dr. Vinay Prasad

In 2018, the FDA authorized the first genetic test that could be marketed directly to consumers – a home test made by 23andme for BRCA mutations to assess breast cancer risk. Since then, the number of genes linked to cancer and other health conditions has continued to increase. Yet what to do with this information has not become any less confusing. In today’s episode, cancer specialist Vinay Prasad, MD, MPH from the University of California, San Francisco explains his anxieties about genetic testing, but also the opportunities. Dr. Prasad also discusses a recent controversial article he wrote suggesting that those who have received both doses of a COVID-19 vaccine can loosen up on the social restrictions. He argues – compellingly -- that for those who have previously been vaccinated, the mental and psychological impacts of these restrictions do not outweigh the small residual infection risk.

**Be sure to subscribe to The Healthy Skeptic MD on your favorite podcast app and on Youtube!
Link for our channel on podcast apps and Youtube: wavve.link/healthyskepticmd